alpha-Tocopheryl/NN
succinate/NN
inhibits/VBZ
monocytic/JJ
cell/NN
adhesion/NN
to/TO
endothelial/JJ
cells/NNS
by/IN
suppressing/VBG
NF-kappa/NN
B/NN
mobilization/NN
./.

The/DT
adherence/NN
of/IN
monocytes/NNS
to/TO
activated/VBN
endothelium/NN
is/VBZ
an/DT
early/JJ
event/NN
in/IN
atherogenesis/NN
./.
=====
Because/IN
antioxidants/NNS
have/VBP
been/VBN
considered/VBN
to/TO
be/VB
of/IN
antiatherosclerotic/JJ
potential/NN
,/,
we/PRP
investigated/VBD
the/DT
effects/NNS
of/IN
alpha-tocopherol/NN
(/(
TCP/NN
)/)
and/CC
its/PRP$
acetate/NN
and/CC
succinate/NN
esters/NNS
on/IN
monocyte/NN
adhesion/NN
to/TO
cytokine-stimulated/JJ
human/JJ
umbilical/JJ
vein/NN
endothelial/JJ
cells/NNS
(/(
HUVEC/NNS
)/)
./.
=====
Endothelial/JJ
cells/NNS
were/VBD
treated/VBN
with/IN
TCP/NN
,/,
alpha-tocopherol/NN
acetate/NN
(/(
TCP/NN
acetate/NN
)/)
,/,
or/CC
alpha-tocopheryl/NN
succinate/NN
(/(
TCP/NN
succinate/NN
)/)
before/IN
stimulation/NN
with/IN
tumor/NN
necrosis/NN
factor-alpha/NN
(/(
TNF-alpha/NN
;/:
10/CD
U/ml/NN
,/,
6/CD
h/NN
)/)
or/CC
interleukin-1/NN
beta/NN
(/(
IL-1/NN
beta/NN
;/:
10/CD
U/ml/NN
,/,
6/CD
h/NN
)/)
./.
=====
Cytokine-stimulated/JJ
cell/NN
surface/NN
expression/NN
of/IN
vascular/JJ
cell/NN
adhesion/NN
molecule-1/NN
(/(
VCAM-1/NN
,/,
CD106/NN
)/)
and/CC
E-selectin/NN
(/(
ELAM-1/NN
,/,
CD62E/NN
)/)
,/,
but/CC
not/RB
of/IN
intercellular/JJ
adhesion/NN
molecule-1/NN
(/(
ICAM-1/NN
,/,
CD54/NN
)/)
,/,
was/VBD
time-/NN
and/CC
dose-/NN
dependently/RB
inhibited/VBN
by/IN
TCP/NN
succinate/NN
but/CC
not/RB
by/IN
TCP/NN
or/CC
TCP/NN
acetate/NN
./.
=====
TCP/NN
succinate/JJ
(/(
200/CD
microM/NN
,/,
24/CD
h/NN
)/)
reduced/VBD
TNF-induced/JJ
VCAM-1/NN
and/CC
E-selectin/NN
expression/NN
from/IN
a/DT
specific/JJ
mean/NN
fluorescence/NN
intensity/NN
of/IN
151/CD
+/-/CC
28/CD
to/TO
12/CD
+/-/CC
4/CD
channels/NNS
and/CC
from/IN
225/CD
+/-/CC
38/CD
to/TO
79/CD
+/-/CC
21/CD
channels/NNS
,/,
respectively/RB
./.
=====
Succinate/NN
alone/RB
had/VBD
no/DT
effect/NN
./.
=====
Decreased/VBN
adhesion/NN
molecule/NN
expression/NN
was/VBD
associated/VBN
with/IN
a/DT
reduction/NN
of/IN
monocytic/JJ
cell/NN
adhesion/NN
./.
=====
TCP/NN
succinate/NN
(/(
20/CD
microM/NN
,/,
72/CD
h/NN
)/)
,/,
but/CC
not/RB
TCP/NN
(/(
200/CD
microM/NN
,/,
72/CD
h/NN
)/)
,/,
reduced/VBD
U-937/NN
cell/NN
adhesion/NN
to/TO
TNF-alpha-stimulated/JJ
(/(
10/CD
U/ml/NN
,/,
6/CD
h/NN
)/)
HUVEC/NNS
by/IN
30/CD
%/NN
(/(
P/NN
</JJR
0.025/CD
)/)
and/CC
to/TO
IL-1/NN
beta-stimulated/JJ
HUVEC/NNS
by/IN
56/CD
%/NN
(/(
P/NN
</JJR
0.010/CD
)/)
./.
=====
Electrophoretic/JJ
mobility-shift/JJ
assays/NNS
of/IN
HUVEC/NNS
nuclear/JJ
proteins/NNS
revealed/VBD
a/DT
decrease/NN
in/IN
TNF-alpha-stimulated/JJ
nuclear/JJ
factor-kappa/NN
B/NN
(/(
NF-kappa/NN
B/NN
)/)
activation/NN
after/IN
pretreatment/NN
of/IN
HUVEC/NNS
with/IN
TCP/NN
succinate/NN
but/CC
not/RB
with/IN
TCP/NN
,/,
TCP/NN
acetate/NN
,/,
or/CC
succinate/NN
alone/RB
./.
=====
In/IN
conclusion/NN
,/,
we/PRP
demonstrate/VBP
that/IN
the/DT
vitamin/NN
E/NN
derivative/NN
TCP/NN
succinate/NN
prevents/VBZ
monocytic/JJ
cell/NN
adhesion/NN
to/TO
cytokine-stimulated/JJ
endothelial/JJ
cells/NNS
by/IN
inhibiting/VBG
the/DT
activation/NN
of/IN
NF-kappa/NN
B/NN
,/,
further/RB
emphasizing/VBG
the/DT
antiatherosclerotic/JJ
potential/NN
of/IN
lipid/NN
soluble/JJ
antioxidants/NNS
./.